Drug
NOVA22007 clinical trials
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
4 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 1
Santen SAS (3) · Campus Bio-Medico University (1)
Studies
Open first, then newest update. How each study uses NOVA22007 is read from its arms, and is right about nine times in ten.
Testing it · 4
- Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal KeratoconjunctivitisCompletedPhase 3Santen SASNCT01751126Written as NOVA22007 ''Ciclosporin''
- NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry EyeCompletedPhase 2Santen SASNCT00739349Written as NOVA22007 ''Cyclosporine''
- Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye SyndromeCompletedPhase 3Santen SASNCT00814515Written as NOVA22007 (Ciclosporin 0.1%)
- Cyclosporin A Eye Drop Treatment in Vernal KeratoconjunctivitisCompletedPhase 3Campus Bio-Medico UniversityNCT00426023Written as Cyclosporine A 0,05% eye drop